Retrospective analysis of The Two Sister Study using haplotype-based association testing to identify loci associated with early-onset breast cancer
James R. Gilbert, James CrayiD, Joseph E. LoseeiD, Gregory M. Cooper
Abstract
Breast cancer is a polygenic disorder and is the leading cause of cancer related mortality among women. Early-onset breast cancer (EOBC) is diagnosed in women prior to 45 years-of-age and is associated with worse clinical outcomes, a more aggressive disease phenotype, and poor prognosis for disease-free survival. While substantial progress has been made in defining the genetics of breast cancer, EOBC remains less well understood. In the current study we perform a retrospective analysis of data derived from The Two Sister Study. The use of alternate strategies for handling age-at-diagnosis in conjunction with haplotype-based methods yielded novel findings that help to explain the heritability of EOBC. These findings are validated through comparison against discordant sibs from The Two Sister Study as well as using data derived The Cancer Genome Atlas (TCGA).
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genome-wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk: Discovery, Replication, and Generalizability Evaluation
Fan Wang, Wonjong Moon, … Yutaka Yasui·Cancer ResearchPeer-reviewed·Nov 9, 2022
- Very high frequencies of Familial Breast Cancer, low BRCA1/2 mutations and high Luminal molecular subtypes in Eastern Saudi Arabia necessitate the hunt for novel breast cancer hub genes
T. Al-Qurashi, S. Balghonaim, … Z. Iqbal·medRxiv·Oct 3, 2023
- Whole exome sequencing and replication for breast cancer among Hispanic/Latino women identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer.
Jovia L. Nierenberg, Aaron W. Adamson, … Susan L. Neuhausen·medRxiv·Jan 25, 2023
- How to identify the best index case in families with hereditary breast and ovarian cancer
Margot Julia Wyrwoll, Lea Fuchs, Daniel E.J. Waschk·bioRxiv·Aug 5, 2019
- No genome-wide correlations and little shared genetic architecture between reproductive life-history traits and estrogen receptor-positive breast cancer risk
Euan A. Young, E. Yagmur Erten, … Hannah L. Dugdale·Molecular Biology and EvolutionPeer-reviewed·Aug 31, 2026
- Segregation analysis of 17,425 population-based breast cancer families: evidence for genetic susceptibility and risk prediction
Shuai Li, Robert J. MacInnis, … Antonis C. Antoniou·The American Journal of Human GeneticsPeer-reviewed·Oct 1, 2022